Cardioprotective glucose-lowering medications: Evidence and uncertainties in a new therapeutic era

Andrew J. Krentz, Robert J Chilton

Research output: Contribution to journal › Editorial

2 Scopus citations

Original language	English (US)
Pages (from-to)	2-3
Number of pages	2
Journal	Cardiovascular Endocrinology and Metabolism
Volume	7
Issue number	1
DOIs	https://doi.org/10.1097/XCE.0000000000000150
State	Published - Mar 1 2018

Cite this

@article{f8801c952cf741d38ddcd3ddf2c98418,

title = "Cardioprotective glucose-lowering medications: Evidence and uncertainties in a new therapeutic era",

author = "Krentz, {Andrew J.} and Chilton, {Robert J}",

year = "2018",

month = mar,

day = "1",

doi = "10.1097/XCE.0000000000000150",

language = "English (US)",

volume = "7",

pages = "2--3",

journal = "Cardiovascular Endocrinology and Metabolism",

issn = "2574-0954",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "1",

}

TY - JOUR

T1 - Cardioprotective glucose-lowering medications

T2 - Evidence and uncertainties in a new therapeutic era

AU - Krentz, Andrew J.

AU - Chilton, Robert J

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85067573524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067573524&partnerID=8YFLogxK

U2 - 10.1097/XCE.0000000000000150

DO - 10.1097/XCE.0000000000000150

M3 - Editorial

AN - SCOPUS:85067573524

VL - 7

SP - 2

EP - 3

JO - Cardiovascular Endocrinology and Metabolism

JF - Cardiovascular Endocrinology and Metabolism

SN - 2574-0954

IS - 1

ER -